Clinical Trial Update: High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk Neuroblastoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating high-dose Iodine-131 metaiodobenzylguanidine (I-131 MIBG), topotecan, and peripheral stem cell transplant in young patients with rela…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Iodine-131 metaiodobenzylguanidine (I-131 MIBG) (metaiodobenzylguanidine)
• Topotecan (topotecan)

Snippet

Sponsor: Children's Cancer and Leukaemia Group | Conditions: Neuroblastoma | Phase 2 | Status: WITHDRAWN